PWP
BIIB icon

Private Wealth Partners’s Biogen BIIB Stock Holding History

Private Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-675
Closed -$203K – 115
2018
Q4 		$203K Hold
675
– – 0.04% 96
2018
Q3 		$238K Buy
+675
New +$232K 0.04% 109
2018
Q2 		– Sell
-800
Closed -$219K – 118
2018
Q1 		$219K Sell
800
-200
-20% -$62.1K 0.04% 119
2017
Q4 		$319K Hold
1,000
– – 0.06% 109
2017
Q3 		$313K Hold
1,000
– – 0.06% 104
2017
Q2 		$271K Buy
1,000
+200
+25% +$52.9K 0.06% 101
2017
Q1 		$219K Hold
800
– – 0.05% 103
2016
Q4 		$227K Buy
800
+100
+14% +$29.6K 0.05% 102
2016
Q3 		$219K Buy
+700
New +$207K 0.05% 111

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Private Wealth Partners's BIIB Position: Q1 2019 in Review

Private Wealth Partners sold out of Biogen (BIIB) in Q1 2019, closing a stake of 675 shares — an estimated $203K sold.

Private Wealth Partners first reported a position in BIIB in Q3 2016 and held it in 9 quarters. The position peaked at $319K in Q4 2017. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Private Wealth Partners reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • Private Wealth Partners sold 675 Biogen shares in Q1 2019, an estimated $203K.
  • Private Wealth Partners first reported a position in Biogen in Q3 2016 and held it in 9 quarters.
  • Private Wealth Partners's Biogen position peaked at $319K in Q4 2017.
  • 1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Private Wealth Partners's 13F filing for Q1 2019, filed 2 May 2019.